Literature DB >> 20398017

Low-dose glucocorticoid therapy in rheumatoid arthritis: an obligatory therapy.

Johannes W J Bijlsma1, Marlies C van der Goes, Jos N Hoes, Johannes W G Jacobs, Frank Buttgereit, John Kirwan.   

Abstract

Glucocorticoids (GCs) are used extensively in patients with rheumatoid arthritis (RA). Recent data on the efficacy of these drugs in alleviating symptoms of inflammation, but also in retarding erosive damage, are presented. In addition, a critical review of the rather limited literature on adverse effects of chronic use of low dose GCs is given. It becomes clear that the net effect of low-dose GCs in the treatment of rheumatoid arthritis favors the beneficial aspects of these drugs above the negative aspects. Prudent use of GCs can be recommended.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20398017     DOI： 10.1111/j.1749-6632.2009.05342.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


  10 in total

Review 1.  The multiple facets of glucocorticoid action in rheumatoid arthritis.

Authors:  Ulrike Baschant; Nancy E Lane; Jan Tuckermann
Journal:  Nat Rev Rheumatol       Date:  2012-10-09       Impact factor: 20.543

2.  Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial.

Authors:  D H van Raalte; M Brands; N J van der Zijl; M H Muskiet; P J W Pouwels; M T Ackermans; H P Sauerwein; M J Serlie; M Diamant
Journal:  Diabetologia       Date:  2011-05-12       Impact factor: 10.122

3.  Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention?

Authors:  J I Gamez-Nava; S A Zavaleta-Muñiz; M L Vazquez-Villegas; A Vega-Lopez; N A Rodriguez-Jimenez; E M Olivas-Flores; N G Gonzalez-Montoya; E G Corona-Sanchez; A D Rocha-Muñoz; M E Martinez-Corral; B T Martin-Márquez; M Vazquez-Del Mercado; J F Muñoz-Valle; E G Cardona-Muñoz; A Celis-De La Rosa; C Cabrera-Pivaral; L Gonzalez-Lopez
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

4.  Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis.

Authors:  Hanh-Hung Dao; Quan-Trung Do; Junichi Sakamoto
Journal:  Clin Rheumatol       Date:  2011-05-06       Impact factor: 2.980

Review 5.  Senescent cells and their secretory phenotype as targets for cancer therapy.

Authors:  Michael C Velarde; Marco Demaria; Judith Campisi
Journal:  Interdiscip Top Gerontol       Date:  2013-01-17

6.  Prevalence of metabolic syndrome in patients with rheumatoid arthritis in Morocco: a cross-sectional study of 179 cases.

Authors:  Fatima Ezzahra Abourazzak; Samia Mansouri; Adil Najdi; Latifa Tahiri; Chakib Nejjari; Taoufik Harzy
Journal:  Clin Rheumatol       Date:  2014-03-20       Impact factor: 2.980

7.  Metabolic syndrome in rheumatoid arthritis: case control study.

Authors:  Samira Rostom; Mariam Mengat; Racha Lahlou; Asmaa Hari; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  BMC Musculoskelet Disord       Date:  2013-04-26       Impact factor: 2.362

8.  Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study.

Authors:  Hanh-Hung Dao; Quan-Trung Do; Junichi Sakamoto
Journal:  Arthritis Res Ther       Date:  2010-12-23       Impact factor: 5.156

Review 9.  Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.

Authors:  Arthur Kavanaugh; Alvin F Wells
Journal:  Rheumatology (Oxford)       Date:  2014-04-10       Impact factor: 7.580

Review 10.  Glucocorticoids in rheumatoid arthritis: current status and future studies.

Authors:  Charlotte Hua; Frank Buttgereit; Bernard Combe
Journal:  RMD Open       Date:  2020-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.